Acumen Pharmaceuticals Inc.
ABOS | NASDAQ
$2.62
+$0.03 (+1.16%)
Sep 22, 2026, 1:47 PM ET · Market open
TTM Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 | Q1 2023 Mar 30, 2023 | Q4 2022 Dec 30, 2022 | Q3 2022 Sep 29, 2022 | Q2 2022 Jun 29, 2022 | Q1 2022 Mar 30, 2022 | Q4 2021 Dec 30, 2021 | Q3 2021 Sep 29, 2021 | Q2 2021 Jun 29, 2021 | Q1 2021 Mar 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Cash & Equivalents | 59.44M | 51.8M | 53.99M | 46.83M | 36.81M | 30.16M | 35.63M | 33.18M | 67.96M | 46.93M | 66.89M | 94.92M | 77.25M | 78M | 130.1M | 157.54M | 111.07M | 108.76M | 122.16M | 135.8M | 68.81M | 41.41M |
Short-Term Investments | 50.75M | 76.6M | 62.88M | 79.78M | 106.56M | 118.99M | 135.93M | 167.16M | 192.52M | 205.58M | 176.64M | 120.52M | 67.63M | 62.41M | 47.5M | 42.65M | 78.84M | 80.33M | 72.08M | 64.16M | n/a | n/a |
Long-Term Investments | n/a | 231K | n/a | 9.44M | 22.8M | 48.8M | 59.97M | 58.55M | 20.91M | 44.11M | 62.55M | 67.27M | 27.31M | 43.42M | 15.84M | n/a | 20M | 27.66M | 31.62M | 29.91M | n/a | n/a |
Other Long-Term Assets | 470K | 83K | 309K | 307K | 311K | 307K | 379K | 406K | 476K | 372K | 454K | 378K | 391K | 195K | 151K | 429K | 344K | 79K | 14K | 13K | 2.37M | 270K |
Receivables | 1M | 772K | 625K | 379K | 315K | 376K | n/a | n/a | 106K | 189K | 225K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 109K | 109K | 109K |
Inventory | n/a | n/a | n/a | n/a | n/a | n/a | 159K | 143K | n/a | n/a | n/a | 67K | 2.68M | 1.39M | 199K | 201K | 141K | 333K | n/a | n/a | n/a | n/a |
Other Current Assets | -1M | 3.57M | 4.16M | 4.46M | 4.55M | 4.94M | 5.73M | 6.14M | 6.12M | 2.6M | 1.96M | 1.88M | 1.94M | 1.68M | 1.42M | 499K | 980K | 1.93M | 2.83M | 2.29M | 1.59M | 464K |
Total Current Assets | 115.51M | 133.09M | 122.25M | 132.15M | 148.4M | 154.95M | 178.31M | 207.63M | 266.92M | 255.83M | 246.62M | 218.6M | 149.54M | 144.03M | 180.33M | 202.56M | 191.05M | 192.1M | 198.66M | 204.91M | 70.57M | 42.1M |
Property-Plant & Equipment | n/a | 197K | 243K | 288K | 335K | 373K | 339K | 385K | 430K | 470K | 503K | 125K | 165K | 218K | 270K | 275K | 280K | 252K | 36K | 13K | 6K | n/a |
Goodwill & Intangibles | 24K | 24K | 29K | 30K | 50K | 56K | n/a | n/a | 184K | 186K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Total Long-Term Assets | 494K | 535K | 581K | 10.07M | 23.49M | 49.53M | 60.69M | 59.34M | 22M | 45.14M | 63.51M | 67.77M | 27.87M | 43.83M | 16.26M | 704K | 20.63M | 27.99M | 31.67M | 29.94M | 2.37M | 270K |
Total Assets | 116.01M | 133.63M | 122.83M | 142.22M | 171.9M | 204.48M | 238.99M | 266.98M | 288.91M | 300.97M | 310.13M | 286.37M | 177.41M | 187.86M | 196.59M | 203.26M | 211.68M | 220.09M | 230.33M | 234.85M | 72.94M | 42.37M |
Account Payables | 13.38M | 1.66M | 554K | 682K | 2.1M | 1.06M | 5.65M | 2.34M | 4.21M | 3.08M | 1.38M | 1.36M | 2.03M | 762K | 1.64M | 2.08M | 1.71M | 1.22M | 1.09M | 382K | 2.91M | 918K |
Deferred Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Short-Term Debt | 19.67M | 14.24M | 8.77M | 3.6M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Current Liabilities | -77K | 1.61M | 4.25M | 4.73M | 2M | 1.29M | 230K | 201K | 1.99M | 1.52M | 3.9M | 81K | 20K | 94K | 131K | 37K | 101K | 99K | 2.96M | 310K | 1.01M | 29.03M |
Total Current Liabilities | 46.85M | 29.23M | 30.01M | 21.96M | 24.86M | 19.32M | 27.61M | 19.91M | 15.37M | 8.47M | 12.97M | 6.1M | 8.53M | 8.78M | 7.81M | 6.61M | 5.13M | 3.94M | 5.15M | 1.49M | 4.52M | 31.18M |
Long-Term Debt | 11.9M | 16.92M | 22.4M | 27.05M | 29.88M | 28.75M | 29.42M | 29.67M | 27.87M | 27.6M | 27.34M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Liabilities | n/a | n/a | n/a | n/a | n/a | 780K | n/a | n/a | 1.51M | 2.61M | 2.56M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 174.5M | 56.65M |
Total Long-Term Liabilities | 11.9M | 16.92M | 22.4M | 27.09M | 29.96M | 29.64M | 29.57M | 29.86M | 29.6M | 30.46M | 30.18M | n/a | n/a | n/a | n/a | n/a | 25K | 62K | n/a | n/a | 174.5M | 56.65M |
Total Liabilities | 58.74M | 46.15M | 52.4M | 49.05M | 54.82M | 48.96M | 57.18M | 49.77M | 44.97M | 38.93M | 43.15M | 6.1M | 8.53M | 8.78M | 7.81M | 6.61M | 5.16M | 4M | 5.15M | 1.49M | 179.02M | 87.84M |
Total Debt | 31.57M | 31.16M | 31.31M | 30.84M | 30.1M | 29M | 29.7M | 29.99M | 28.21M | 27.97M | 28.49M | 2K | 29K | 67K | 105K | 133K | 167K | 201K | n/a | n/a | n/a | n/a |
Book Value | 57.26M | 87.48M | 70.43M | 93.17M | 117.08M | 155.52M | 181.82M | 217.2M | 243.95M | 262.03M | 266.97M | 280.27M | 168.87M | 179.09M | 188.78M | 196.65M | 206.52M | 216.09M | 225.18M | 233.36M | -106.08M | -45.46M |
Book Value Per Share | 0.79 | 1.38 | 1.16 | 1.54 | 1.93 | 2.57 | 3.03 | 3.62 | 4.06 | 4.38 | 4.60 | 5.17 | 4.12 | 4.37 | 4.62 | 4.86 | 5.10 | 5.34 | 5.88 | 6.10 | -2.74 | -1.23 |
Common Stock | 7K | 7K | 6K | 6K | 6K | 6K | 6K | 6K | 6K | 6K | 6K | 6K | 4K | 4K | 4K | 4K | 4K | 4K | 4K | 4K | n/a | n/a |
Retained Earnings | -499.92M | -467.2M | -446.46M | -421.32M | -394.87M | -353.92M | -325.13M | -287.97M | -258.21M | -237.67M | -222.8M | -206.3M | -193.34M | -181.73M | -170.43M | -157.56M | -146.85M | -136.7M | -127.57M | -119.22M | -115.32M | -53.96M |
Comprehensive Income | -13K | 21K | 83K | 109K | 23K | 15K | -48K | 518K | -164K | -144K | 312K | -509K | -646K | -524K | -751K | -965K | -965K | -814K | -231K | -28K | n/a | n/a |
Shareholders Equity | 57.26M | 87.48M | 70.43M | 93.17M | 117.08M | 155.52M | 181.82M | 217.2M | 243.95M | 262.03M | 266.97M | 280.27M | 168.87M | 179.09M | 188.78M | 196.65M | 206.52M | 216.09M | 225.18M | 233.36M | -106.08M | -45.46M |
Total Investments | 50.75M | 76.6M | 62.88M | 89.22M | 129.36M | 167.78M | 195.9M | 225.71M | 213.43M | 249.69M | 239.19M | 187.79M | 94.94M | 105.83M | 63.34M | 42.65M | 98.85M | 107.98M | 103.69M | 94.07M | n/a | n/a |
Add to Watchlist
Select watchlists to add or remove ABOS